---
title: "MBX.US (MBX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/MBX.US/news.md"
symbol: "MBX.US"
name: "MBX.US"
parent: "https://longbridge.com/en/quote/MBX.US.md"
datetime: "2026-05-20T18:22:02.755Z"
locales:
  - [en](https://longbridge.com/en/quote/MBX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MBX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MBX.US/news.md)
---

# MBX.US (MBX.US) — Related News

### [MBX Biosciences (MBX) Is Down 20.8% After Wider Loss, Obesity Data And New CCO - Has The Bull Case Changed?](https://longbridge.com/en/news/286684097.md)
*2026-05-17T22:18:16.000Z*
> MBX Biosciences reported a Q1 2026 net loss of $23.52 million and appointed Mark R. Soued as Chief Commercial Officer. D

### [LifeSci Capital Remains a Buy on MBX Biosciences, Inc. (MBX)](https://longbridge.com/en/news/286648301.md)
*2026-05-16T14:36:42.000Z*
> LifeSci Capital analyst Patrick Dolezal has maintained a Buy rating on MBX Biosciences, Inc. with a price target of $91.

### [MBX Biosciences (NASDAQ:MBX) Trading Down 8.8%  - Here's What Happened](https://longbridge.com/en/news/286150529.md)
*2026-05-12T20:15:24.000Z*
> MBX Biosciences (NASDAQ:MBX) shares fell 8.8% to $36.54 amid increased trading volume. Analysts remain optimistic, with 

### [Interpace Biosciences Announces First Quarter 2026 Financial and Business Results | IDXG Stock News](https://longbridge.com/en/news/286157096.md)
*2026-05-12T12:06:00.000Z*
> Interpace Biosciences reported Q1 2026 revenue of $9.0 million, a 12% increase in thyroid revenue year-over-year. The co

### [MBX Biosciences Obesity Day Spotlights Monthly GLP-1 Hope and Pipeline Push](https://longbridge.com/en/news/285984471.md)
*2026-05-11T19:09:16.000Z*
> MBX Biosciences highlighted its lead obesity candidate MBX 4291 during its Obesity Day event, presenting preliminary cli